These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 27077924)

  • 21. Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
    ; Gross JG; Glassman AR; Jampol LM; Inusah S; Aiello LP; Antoszyk AN; Baker CW; Berger BB; Bressler NM; Browning D; Elman MJ; Ferris FL; Friedman SM; Marcus DM; Melia M; Stockdale CR; Sun JK; Beck RW
    JAMA; 2015 Nov; 314(20):2137-2146. PubMed ID: 26565927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of panretinal laser photocoagulation on visual acuity, visual fields and on subjective visual impairment in preproliferative and early proliferative diabetic retinopathy.
    Henricsson M; Heijl A
    Acta Ophthalmol (Copenh); 1994 Oct; 72(5):570-5. PubMed ID: 7887154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinal Nonperfusion in Proliferative Diabetic Retinopathy Before and After Panretinal Photocoagulation Assessed by Widefield OCT Angiography.
    Russell JF; Al-Khersan H; Shi Y; Scott NL; Hinkle JW; Fan KC; Lyu C; Feuer WJ; Gregori G; Rosenfeld PJ
    Am J Ophthalmol; 2020 May; 213():177-185. PubMed ID: 32006481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of Intravitreous Ranibizumab Compared With Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Secondary Analysis From a Diabetic Retinopathy Clinical Research Network Randomized Clinical Trial.
    Hutton DW; Stein JD; Bressler NM; Jampol LM; Browning D; Glassman AR;
    JAMA Ophthalmol; 2017 Jun; 135(6):576-584. PubMed ID: 28492920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy.
    Filho JA; Messias A; Almeida FP; Ribeiro JA; Costa RA; Scott IU; Jorge R
    Acta Ophthalmol; 2011 Nov; 89(7):e567-72. PubMed ID: 21726427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preservation of retinal sensitivity in central visual field after panretinal photocoagulation in diabetics.
    Yoon YH; Lee J; Kim YJ
    Korean J Ophthalmol; 1996 Jun; 10(1):48-54. PubMed ID: 8755202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contrast sensitivity evaluation in high risk proliferative diabetic retinopathy treated with panretinal photocoagulation associated or not with intravitreal bevacizumab injections: a randomised clinical trial.
    Preti RC; Ramirez LM; Monteiro ML; Carra MK; Pelayes DE; Takahashi WY
    Br J Ophthalmol; 2013 Jul; 97(7):885-9. PubMed ID: 23686001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of laser photocoagulation for diabetic retinopathy using 532-nm standard laser versus multispot pattern scan laser.
    Nagpal M; Marlecha S; Nagpal K
    Retina; 2010 Mar; 30(3):452-8. PubMed ID: 20216293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of multifocal electroretinography and optical coherence tomography in eyes undergoing panretinal photocoagulation for diabetic retinopathy.
    Zhu Y; Zhang T; Wang KY; Xu GZ
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(10):6358-64. PubMed ID: 25146984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of 577-nm Multispot and Standard Single-Spot Photocoagulation for Diabetic Retinopathy.
    Passos RM; Belucio-Neto J; Xavier CO; Novais EA; Maia M; Farah ME
    Ophthalmologica; 2019; 241(4):202-210. PubMed ID: 30332674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural and functional changes to the retina and optic nerve following panretinal photocoagulation over a 2-year time period.
    Filek R; Hooper P; Sheidow T; Gonder J; Varma DK; Heckler L; Hodge W; Chakrabarti S; Hutnik CML
    Eye (Lond); 2017 Aug; 31(8):1237-1244. PubMed ID: 28452993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of pain experience and time required for pre-planned navigated peripheral laser versus conventional multispot laser in the treatment of diabetic retinopathy.
    Amoroso F; Pedinielli A; Astroz P; Semoun O; Capuano V; Miere A; Souied EH
    Acta Diabetol; 2020 May; 57(5):535-541. PubMed ID: 31749047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti-Vascular Endothelial Growth Factor.
    Obeid A; Su D; Patel SN; Uhr JH; Borkar D; Gao X; Fineman MS; Regillo CD; Maguire JI; Garg SJ; Hsu J
    Ophthalmology; 2019 Mar; 126(3):407-413. PubMed ID: 30077614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Observation of retinal neovascularization using optical coherence tomography angiography after panretinal photocoagulation for proliferative diabetic retinopathy.
    Feng HE; Weihong YU; Dong F
    BMC Ophthalmol; 2021 Jun; 21(1):252. PubMed ID: 34098891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Panretinal Photocoagulation Does Not Change Macular Perfusion in Eyes With Proliferative Diabetic Retinopathy.
    Lorusso M; Milano V; Nikolopoulou E; Ferrari LM; Cicinelli MV; Querques G; Ferrari TM
    Ophthalmic Surg Lasers Imaging Retina; 2019 Mar; 50(3):174-178. PubMed ID: 30893451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term visual outcome in proliferative diabetic retinopathy patients after panretinal photocoagulation.
    Dogru M; Nakamura M; Inoue M; Yamamoto M
    Jpn J Ophthalmol; 1999; 43(3):217-24. PubMed ID: 10413257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term review of driving potential following bilateral panretinal photocoagulation for proliferative diabetic retinopathy.
    Vernon SA; Bhagey J; Boraik M; El-Defrawy H
    Diabet Med; 2009 Jan; 26(1):97-9. PubMed ID: 19125769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema.
    ; Fong DS; Strauber SF; Aiello LP; Beck RW; Callanan DG; Danis RP; Davis MD; Feman SS; Ferris F; Friedman SM; Garcia CA; Glassman AR; Han DP; Le D; Kollman C; Lauer AK; Recchia FM; Solomon SD
    Arch Ophthalmol; 2007 Apr; 125(4):469-80. PubMed ID: 17420366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pascal panretinal laser ablation and regression analysis in proliferative diabetic retinopathy: Manchester Pascal Study Report 4.
    Muqit MM; Marcellino GR; Henson DB; Young LB; Turner GS; Stanga PE
    Eye (Lond); 2011 Nov; 25(11):1447-56. PubMed ID: 21818132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient Comfort with Yellow (577 nm) vs. Green (532 nm) Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy.
    Adam MK; Weinstock BM; Kasi SK; Ehmann DS; Hsu J; Garg SJ; Ho AC; Chiang A
    Ophthalmol Retina; 2018 Feb; 2(2):91-95. PubMed ID: 31047351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.